Physician-Industry Interactions and Anti–Vascular Endothelial Growth Factor Use Among US Ophthalmologists

Authors:

Abstract
In an effort to increase the transparency of physician-industry relationships, the Physician Payments Sunshine Act was signed into law in 2010 in the United States and mandates public posting of all payments to physicians by the pharmaceutical industry. The Physician Payments Sunshine Act registry began tracking industry payments to physicians beginning August 2013, and it provides unique insight into the financial relationship between physicians and industry in the United States. For example, during the last 5 months of 2013, a total of 470 000 US health care professionals received $3.4 billion in industry payments.1 Although this registry provides valuable understanding into the extent of physician-industry interactions, it does little to assess whether physician-industry relationships influence physician practice habits.

This publication has 26 references indexed in Scilit: